A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy
Condition: Diabetic Neuropathy Intervention: Drug: WST-057 (4% pirenzepine) Lose Dose 2mL Sponsor: WinSanTor, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Diabetes | Diabetes Type 2 | Endocrinology | Neurology | Peripheral Neuropathy | Research | Study